image
Ontrak, Inc. OTRKP
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
Watchlist
$ 0.2741
0 %
$ 7.3 M
Market Cap
-0.1
P/E
1. INTRINSIC VALUE

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health.[ Read More ]

The intrinsic value of one OTRKP stock under the base case scenario is HIDDEN Compared to the current market price of 0.274 USD, Ontrak, Inc. is HIDDEN

OTRKP Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart OTRKP

image
FINANCIALS
12.7 M REVENUE
-12.20%
Growth Rates
1Year -12.20%
3Years -46.42%
5Years -3.44%
7Years 8.77%
10Years 30.85%
-20.7 M OPERATING INCOME
52.12%
Growth Rates
1Year 52.12%
3Years -11.48%
5Years -8.70%
7Years -17.78%
10Years -11.28%
-27.9 M NET INCOME
45.86%
Growth Rates
1Year 45.86%
3Years -7.13%
5Years -14.46%
7Years -6.53%
10Years -19.56%
-15.5 M OPERATING CASH FLOW
35.33%
Growth Rates
1Year 35.33%
3Years -35.12%
5Years -12.57%
7Years -15.29%
10Years -10.07%
-285 K INVESTING CASH FLOW
75.35%
Growth Rates
1Year 75.35%
3Years 60.54%
5Years -41.12%
7Years -17.90%
10Years -0.73%
15.8 M FINANCING CASH FLOW
150.69%
Growth Rates
1Year 150.69%
3Years -45.99%
5Years 16.65%
7Years 15.50%
10Years 14.19%
2.57 M REVENUE
4.81%
Growth Rates
1Year -12.20%
3Years -46.42%
5Years -3.44%
7Years 8.77%
10Years 30.85%
-5.11 M OPERATING INCOME
-26.19%
Growth Rates
1Year 52.12%
3Years -11.48%
5Years -8.70%
7Years -17.78%
10Years -11.28%
-5.58 M NET INCOME
45.77%
Growth Rates
1Year 45.86%
3Years -7.13%
5Years -14.46%
7Years -6.53%
10Years -19.56%
-1.41 M OPERATING CASH FLOW
68.41%
Growth Rates
1Year 35.33%
3Years -35.12%
5Years -12.57%
7Years -15.29%
10Years -10.07%
-28 K INVESTING CASH FLOW
24.32%
Growth Rates
1Year 75.35%
3Years 60.54%
5Years -41.12%
7Years -17.90%
10Years -0.73%
2.11 M FINANCING CASH FLOW
-60.84%
Growth Rates
1Year 150.69%
3Years -45.99%
5Years 16.65%
7Years 15.50%
10Years 14.19%
Balance Sheet Decomposition Ontrak, Inc.
image
Current Assets 12.7 M
Cash & Short-Term Investments 9.7 M
Receivables 607 K
Other Current Assets 2.34 M
Non-Current Assets 7.2 M
Long-Term Investments 0
PP&E 1.11 M
Other Non-Current Assets 6.09 M
Current Liabilities 3.94 M
Accounts Payable 563 K
Short-Term Debt 112 K
Other Current Liabilities 3.27 M
Non-Current Liabilities 1.63 M
Long-Term Debt 1.63 M
Other Non-Current Liabilities 0
EFFICIENCY
Earnings Waterfall Ontrak, Inc.
image
Revenue 12.7 M
Cost Of Revenue 3.94 M
Gross Profit 8.8 M
Operating Expenses 29.5 M
Operating Income -20.7 M
Other Expenses 7.24 M
Net Income -27.9 M
RATIOS
69.06% GROSS MARGIN
69.06%
Averages
1Year 69.06%
3Years 60.18%
5Years 53.95%
7Years 44.81%
10Years 39.36%
-162.25% OPERATING MARGIN
-162.25%
Averages
1Year -162.25%
3Years -160.80%
5Years -111.49%
7Years -112.32%
10Years -148.83%
-219.10% NET MARGIN
-219.10%
Averages
1Year -219.10%
3Years -206.19%
5Years -144.11%
7Years -141.50%
10Years -285.81%
-195.64% ROE
-195.64%
Averages
1Year -195.64%
3Years -395.21%
5Years -222.71%
7Years -352.87%
10Years -225.01%
-140.68% ROA
-140.68%
Averages
1Year -140.68%
3Years -126.85%
5Years -101.19%
7Years -133.82%
10Years -292.80%
-130.53% ROIC
-130.53%
Averages
1Year -130.53%
3Years -142.94%
5Years -138.23%
7Years -139.14%
10Years -74.18%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Ontrak, Inc.
image
Net Income -27.9 M
Depreciation & Amortization 6.38 M
Capital Expenditures -285 K
Stock-Based Compensation 2.95 M
Change in Working Capital -786 K
Others 3.38 M
Free Cash Flow -15.8 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Ontrak, Inc.
image
OTRKP has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.594 USD DIVIDEND PER SHARE
5. COMPETITION

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules for severe recalcitrant nodular acne.

image
-0.161 USD
FBIOP
Overvalued 103.16%

FAT Brands Inc., a multi-brand franchising company, acquires, develops, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts worldwide.

image
0 USD
FATBP
Overvalued 100.00%

Oxford Lane Capital Corp. is a close ended fund launched and managed by Oxford Lane Management LLC. It invests in fixed income securities.

image
-0.725 USD
OXLCP
Overvalued 103.02%
6. Ownership
Insider Ownership Ontrak, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
78.6 M USD 1
9-12 MONTHS
Date Value Insider Amount Avg Price
10 months ago
Dec 20, 2023
Bought 31.2 M USD
PEIZER TERREN S
10 percent owner
+ 36666666
 0.85 USD
10 months ago
Dec 20, 2023
Bought 1.83 K USD
PEIZER TERREN S
10 percent owner
+ 18333333
 0.0001 USD
1 year ago
Nov 14, 2023
Bought 31.2 M USD
PEIZER TERREN S
10 percent owner
+ 36666666
 0.85 USD
1 year ago
Nov 14, 2023
Bought 1.83 K USD
PEIZER TERREN S
10 percent owner
+ 18333333
 0.0001 USD
1 year ago
Nov 14, 2023
Bought 16.2 M USD
PEIZER TERREN S
10 percent owner
+ 18054791
 0.9 USD
1 year ago
Nov 14, 2023
Sell 0 USD
PEIZER TERREN S
10 percent owner
- 0
 0.9 USD
1 year ago
Nov 14, 2023
Bought 0 USD
PEIZER TERREN S
10 percent owner
+ 0
 0.9 USD
1 year ago
Mar 06, 2023
Bought 4 M USD
PEIZER TERREN S
10 percent owner
+ 10000000
 0.4 USD
1 year ago
Mar 06, 2023
Bought 4 M USD
PEIZER TERREN S
10 percent owner
+ 8888889
 0.45 USD
3 years ago
Sep 27, 2021
Sell 67.2 K USD
PEIZER TERREN S
Executive Chairman
- 6813
 9.8665 USD
3 years ago
Sep 27, 2021
Sell 85.7 K USD
PEIZER TERREN S
Executive Chairman
- 8187
 10.4688 USD
3 years ago
Sep 28, 2021
Sell 139 K USD
PEIZER TERREN S
Executive Chairman
- 13567
 10.2283 USD
3 years ago
Sep 22, 2021
Sell 153 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.2179 USD
3 years ago
Sep 23, 2021
Sell 152 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.1094 USD
3 years ago
Sep 24, 2021
Sell 144 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 9.5943 USD
3 years ago
Sep 17, 2021
Sell 162 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.8033 USD
3 years ago
Sep 20, 2021
Sell 160 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.6975 USD
3 years ago
Sep 21, 2021
Sell 156 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.3951 USD
3 years ago
Sep 14, 2021
Sell 164 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.942 USD
3 years ago
Sep 15, 2021
Sell 158 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.5651 USD
3 years ago
Sep 16, 2021
Sell 159 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.5743 USD
3 years ago
Sep 09, 2021
Sell 175 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 11.6926 USD
3 years ago
Sep 10, 2021
Sell 167 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 11.1438 USD
3 years ago
Sep 13, 2021
Sell 165 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.9976 USD
3 years ago
Sep 03, 2021
Sell 184 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 12.2489 USD
3 years ago
Sep 07, 2021
Sell 176 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 11.716 USD
3 years ago
Sep 08, 2021
Sell 167 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 11.1161 USD
3 years ago
Aug 31, 2021
Sell 171 K USD
PEIZER TERREN S
Executive Chairman
- 14433
 11.8384 USD
3 years ago
Aug 31, 2021
Sell 7.03 K USD
PEIZER TERREN S
Executive Chairman
- 567
 12.3987 USD
3 years ago
Sep 01, 2021
Sell 180 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 11.9677 USD
3 years ago
Sep 02, 2021
Sell 146 K USD
PEIZER TERREN S
Executive Chairman
- 11824
 12.3357 USD
3 years ago
Sep 02, 2021
Sell 41.1 K USD
PEIZER TERREN S
Executive Chairman
- 3176
 12.9507 USD
3 years ago
Aug 27, 2021
Sell 168 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 11.1908 USD
3 years ago
Aug 30, 2021
Sell 152 K USD
PEIZER TERREN S
Executive Chairman
- 12632
 12.0621 USD
3 years ago
Aug 30, 2021
Sell 30.5 K USD
PEIZER TERREN S
Executive Chairman
- 2368
 12.8831 USD
3 years ago
Aug 24, 2021
Sell 164 K USD
PEIZER TERREN S
Executive Chairman
- 15000
 10.9116 USD
3 years ago
Aug 25, 2021
Sell 159 K USD
PEIZER TERREN S
Executive Chairman
- 13843
 11.4544 USD
3 years ago
Aug 25, 2021
Sell 13.7 K USD
PEIZER TERREN S
Executive Chairman
- 1157
 11.8323 USD
3 years ago
Aug 26, 2021
Sell 156 K USD
PEIZER TERREN S
Executive Chairman
- 13529
 11.519 USD
3 years ago
Aug 26, 2021
Sell 18.1 K USD
PEIZER TERREN S
Executive Chairman
- 1471
 12.2952 USD
3 years ago
Aug 19, 2021
Sell 67.1 K USD
PEIZER TERREN S
Executive Chairman
- 5664
 11.8479 USD
3 years ago
Aug 19, 2021
Sell 65.1 K USD
PEIZER TERREN S
Executive Chairman
- 4991
 13.0366 USD
3 years ago
Aug 19, 2021
Sell 45.2 K USD
PEIZER TERREN S
Executive Chairman
- 3215
 14.0612 USD
3 years ago
Aug 19, 2021
Sell 16.6 K USD
PEIZER TERREN S
Executive Chairman
- 1130
 14.7331 USD
3 years ago
Aug 20, 2021
Sell 20.1 K USD
PEIZER TERREN S
Executive Chairman
- 1938
 10.3932 USD
3 years ago
Aug 20, 2021
Sell 146 K USD
PEIZER TERREN S
Executive Chairman
- 13062
 11.1638 USD
3 years ago
Aug 23, 2021
Sell 164 K USD
PEIZER TERREN S
Executive Chairman
- 14770
 11.0898 USD
3 years ago
Aug 23, 2021
Sell 2.68 K USD
PEIZER TERREN S
Executive Chairman
- 230
 11.6523 USD
3 years ago
Aug 16, 2021
Sell 304 K USD
PEIZER TERREN S
Executive Chairman
- 13140
 23.1634 USD
3 years ago
Aug 16, 2021
Sell 43.8 K USD
PEIZER TERREN S
Executive Chairman
- 1860
 23.5571 USD
3 years ago
Aug 17, 2021
Sell 185 K USD
PEIZER TERREN S
Executive Chairman
- 8804
 20.9623 USD
3 years ago
Aug 17, 2021
Sell 136 K USD
PEIZER TERREN S
Executive Chairman
- 6196
 21.9773 USD
3 years ago
Aug 18, 2021
Sell 240 K USD
PEIZER TERREN S
Executive Chairman
- 11311
 21.2026 USD
3 years ago
Aug 18, 2021
Sell 80.1 K USD
PEIZER TERREN S
Executive Chairman
- 3689
 21.7259 USD
3 years ago
Aug 11, 2021
Sell 818 K USD
PEIZER TERREN S
Executive Chairman
- 30173
 27.1185 USD
3 years ago
Aug 11, 2021
Sell 282 K USD
PEIZER TERREN S
Executive Chairman
- 10411
 27.1185 USD
3 years ago
Aug 11, 2021
Sell 662 K USD
PEIZER TERREN S
Executive Chairman
- 24405
 27.1185 USD
3 years ago
Aug 11, 2021
Sell 296 K USD
PEIZER TERREN S
Executive Chairman
- 10932
 27.1185 USD
3 years ago
Aug 11, 2021
Sell 235 K USD
PEIZER TERREN S
Executive Chairman
- 8676
 27.1185 USD
3 years ago
Aug 11, 2021
Sell 235 K USD
PEIZER TERREN S
Executive Chairman
- 8676
 27.1185 USD
3 years ago
Aug 11, 2021
Sell 174 K USD
PEIZER TERREN S
Executive Chairman
- 6420
 27.1185 USD
3 years ago
Jul 20, 2021
Sell 81.5 K USD
PEIZER TERREN S
Executive Chairman
- 2972
 27.421 USD
3 years ago
Jul 20, 2021
Sell 116 K USD
PEIZER TERREN S
Executive Chairman
- 4091
 28.3036 USD
3 years ago
Jul 14, 2021
Sell 239 K USD
PEIZER TERREN S
Executive Chairman
- 8315
 28.783 USD
3 years ago
Jul 14, 2021
Sell 79.1 K USD
PEIZER TERREN S
Executive Chairman
- 2685
 29.4566 USD
3 years ago
Jul 15, 2021
Sell 260 K USD
PEIZER TERREN S
Executive Chairman
- 9400
 27.6535 USD
3 years ago
Jul 15, 2021
Sell 45.2 K USD
PEIZER TERREN S
Executive Chairman
- 1600
 28.2226 USD
3 years ago
Jul 19, 2021
Sell 220 K USD
PEIZER TERREN S
Executive Chairman
- 8063
 27.3083 USD
3 years ago
Jul 19, 2021
Sell 82.4 K USD
PEIZER TERREN S
Executive Chairman
- 2937
 28.07 USD
3 years ago
Jul 12, 2021
Sell 307 K USD
PEIZER TERREN S
Executive Chairman
- 9978
 30.7567 USD
3 years ago
Jul 12, 2021
Sell 29 K USD
PEIZER TERREN S
Executive Chairman
- 922
 31.4879 USD
3 years ago
Jul 12, 2021
Sell 3.24 K USD
PEIZER TERREN S
Executive Chairman
- 100
 32.36 USD
3 years ago
Jul 13, 2021
Sell 327 K USD
PEIZER TERREN S
Executive Chairman
- 10900
 30.0281 USD
3 years ago
Jul 13, 2021
Sell 3.08 K USD
PEIZER TERREN S
Executive Chairman
- 100
 30.85 USD
3 years ago
Jul 14, 2021
Sell 239 K USD
PEIZER TERREN S
Executive Chairman
- 8315
 28.783 USD
3 years ago
Jul 14, 2021
Sell 79.1 K USD
PEIZER TERREN S
Executive Chairman
- 2685
 29.4566 USD
3 years ago
Jul 07, 2021
Sell 315 K USD
PEIZER TERREN S
Executive Chairman
- 10477
 30.0723 USD
3 years ago
Jul 07, 2021
Sell 16.2 K USD
PEIZER TERREN S
Executive Chairman
- 523
 30.9422 USD
3 years ago
Jul 08, 2021
Sell 50 K USD
PEIZER TERREN S
Executive Chairman
- 1700
 29.3842 USD
3 years ago
Jul 08, 2021
Sell 24 K USD
PEIZER TERREN S
Executive Chairman
- 800
 30.025 USD
3 years ago
Jul 08, 2021
Sell 184 K USD
PEIZER TERREN S
Executive Chairman
- 5888
 31.3058 USD
3 years ago
Jul 08, 2021
Sell 84.4 K USD
PEIZER TERREN S
Executive Chairman
- 2612
 32.3142 USD
3 years ago
Jul 09, 2021
Sell 130 K USD
PEIZER TERREN S
Executive Chairman
- 4200
 30.9277 USD
3 years ago
Jul 09, 2021
Sell 211 K USD
PEIZER TERREN S
Executive Chairman
- 6600
 32.0266 USD
3 years ago
Jul 09, 2021
Sell 6.49 K USD
PEIZER TERREN S
Executive Chairman
- 200
 32.46 USD
3 years ago
Jul 01, 2021
Sell 287 K USD
PEIZER TERREN S
Executive Chairman
- 8759
 32.7606 USD
3 years ago
Jul 01, 2021
Sell 74.3 K USD
PEIZER TERREN S
Executive Chairman
- 2241
 33.1561 USD
3 years ago
Jul 02, 2021
Sell 301 K USD
PEIZER TERREN S
Executive Chairman
- 9592
 31.4213 USD
3 years ago
Jul 02, 2021
Sell 45.7 K USD
PEIZER TERREN S
Executive Chairman
- 1408
 32.4664 USD
3 years ago
Jul 06, 2021
Sell 333 K USD
PEIZER TERREN S
Executive Chairman
- 10700
 31.1137 USD
3 years ago
Jul 06, 2021
Sell 9.5 K USD
PEIZER TERREN S
Executive Chairman
- 300
 31.6833 USD
3 years ago
Jun 28, 2021
Sell 102 K USD
PEIZER TERREN S
Executive Chairman
- 3010
 33.8272 USD
3 years ago
Jun 28, 2021
Sell 165 K USD
PEIZER TERREN S
Executive Chairman
- 4740
 34.7954 USD
3 years ago
Jun 28, 2021
Sell 115 K USD
PEIZER TERREN S
Executive Chairman
- 3250
 35.4229 USD
3 years ago
Jun 29, 2021
Sell 289 K USD
PEIZER TERREN S
Executive Chairman
- 8530
 33.8587 USD
3 years ago
Jun 29, 2021
Sell 86.4 K USD
PEIZER TERREN S
Executive Chairman
- 2470
 34.9742 USD
3 years ago
Jun 30, 2021
Sell 350 K USD
PEIZER TERREN S
Executive Chairman
- 10800
 32.4114 USD
3 years ago
Jun 30, 2021
Sell 6.66 K USD
PEIZER TERREN S
Executive Chairman
- 200
 33.2998 USD
3 years ago
Jun 23, 2021
Sell 346 K USD
PEIZER TERREN S
Executive Chairman
- 10200
 33.8966 USD
3 years ago
Jun 23, 2021
Sell 27.6 K USD
PEIZER TERREN S
Executive Chairman
- 800
 34.4857 USD
3 years ago
Jun 24, 2021
Sell 222 K USD
PEIZER TERREN S
Executive Chairman
- 6420
 34.6085 USD
3 years ago
Jun 24, 2021
Sell 161 K USD
PEIZER TERREN S
Executive Chairman
- 4580
 35.2508 USD
3 years ago
Jun 25, 2021
Sell 323 K USD
PEIZER TERREN S
Executive Chairman
- 9557
 33.8195 USD
3 years ago
Jun 25, 2021
Sell 49.9 K USD
PEIZER TERREN S
Executive Chairman
- 1443
 34.606 USD
3 years ago
Jun 18, 2021
Sell 286 K USD
PEIZER TERREN S
Executive Chairman
- 8321
 34.312 USD
3 years ago
Jun 18, 2021
Sell 94.1 K USD
PEIZER TERREN S
Executive Chairman
- 2679
 35.1198 USD
3 years ago
Jun 21, 2021
Sell 269 K USD
PEIZER TERREN S
Executive Chairman
- 8100
 33.15 USD
3 years ago
Jun 21, 2021
Sell 91.6 K USD
PEIZER TERREN S
Executive Chairman
- 2700
 33.9331 USD
3 years ago
Jun 21, 2021
Sell 7.02 K USD
PEIZER TERREN S
Executive Chairman
- 200
 35.125 USD
3 years ago
Jun 22, 2021
Sell 237 K USD
PEIZER TERREN S
Executive Chairman
- 7060
 33.526 USD
3 years ago
Jun 22, 2021
Sell 135 K USD
PEIZER TERREN S
Executive Chairman
- 3940
 34.3518 USD
3 years ago
Jun 15, 2021
Sell 268 K USD
PEIZER TERREN S
Executive Chairman
- 8332
 32.1854 USD
3 years ago
Jun 15, 2021
Sell 87.6 K USD
PEIZER TERREN S
Executive Chairman
- 2668
 32.8389 USD
3 years ago
Jun 16, 2021
Sell 194 K USD
PEIZER TERREN S
Executive Chairman
- 5882
 32.9406 USD
3 years ago
Jun 16, 2021
Sell 172 K USD
PEIZER TERREN S
Executive Chairman
- 5118
 33.5387 USD
3 years ago
Jun 17, 2021
Sell 150 K USD
PEIZER TERREN S
Executive Chairman
- 4493
 33.4603 USD
3 years ago
Jun 17, 2021
Sell 202 K USD
PEIZER TERREN S
Executive Chairman
- 5902
 34.2987 USD
3 years ago
Jun 17, 2021
Sell 21.1 K USD
PEIZER TERREN S
Executive Chairman
- 605
 34.8817 USD
3 years ago
Jun 10, 2021
Sell 66.6 K USD
PEIZER TERREN S
Executive Chairman
- 2074
 32.1163 USD
3 years ago
Jun 10, 2021
Sell 119 K USD
PEIZER TERREN S
Executive Chairman
- 3556
 33.3729 USD
3 years ago
Jun 10, 2021
Sell 101 K USD
PEIZER TERREN S
Executive Chairman
- 2970
 34.0557 USD
3 years ago
Jun 10, 2021
Sell 3.36 K USD
PEIZER TERREN S
Executive Chairman
- 94
 35.75 USD
3 years ago
Jun 10, 2021
Sell 62 K USD
PEIZER TERREN S
Executive Chairman
- 1706
 36.3571 USD
3 years ago
Jun 10, 2021
Sell 22.2 K USD
PEIZER TERREN S
Executive Chairman
- 600
 36.9717 USD
3 years ago
Jun 11, 2021
Sell 230 K USD
PEIZER TERREN S
Executive Chairman
- 7398
 31.0763 USD
3 years ago
Jun 11, 2021
Sell 90.3 K USD
PEIZER TERREN S
Executive Chairman
- 2802
 32.2182 USD
3 years ago
Jun 11, 2021
Sell 26.3 K USD
PEIZER TERREN S
Executive Chairman
- 800
 32.8422 USD
3 years ago
Jun 14, 2021
Sell 66.7 K USD
PEIZER TERREN S
Executive Chairman
- 2100
 31.7654 USD
3 years ago
Jun 14, 2021
Sell 71.4 K USD
PEIZER TERREN S
Executive Chairman
- 2200
 32.4579 USD
3 years ago
Jun 14, 2021
Sell 224 K USD
PEIZER TERREN S
Executive Chairman
- 6700
 33.4045 USD
3 years ago
Jun 07, 2021
Sell 271 K USD
PEIZER TERREN S
Executive Chairman
- 8899
 30.5008 USD
3 years ago
Jun 07, 2021
Sell 65.5 K USD
PEIZER TERREN S
Executive Chairman
- 2101
 31.165 USD
3 years ago
Jun 08, 2021
Sell 121 K USD
PEIZER TERREN S
Executive Chairman
- 3799
 31.7723 USD
3 years ago
Jun 08, 2021
Sell 94.2 K USD
PEIZER TERREN S
Executive Chairman
- 2900
 32.4985 USD
3 years ago
Jun 08, 2021
Sell 36.8 K USD
PEIZER TERREN S
Executive Chairman
- 1100
 33.4623 USD
3 years ago
Jun 08, 2021
Sell 185 K USD
PEIZER TERREN S
Executive Chairman
- 5295
 34.9205 USD
3 years ago
Jun 08, 2021
Sell 1.27 M USD
PEIZER TERREN S
Executive Chairman
- 35801
 35.458 USD
3 years ago
Jun 08, 2021
Sell 439 K USD
PEIZER TERREN S
Executive Chairman
- 12105
 36.2988 USD
3 years ago
Jun 09, 2021
Sell 140 K USD
PEIZER TERREN S
Executive Chairman
- 3870
 36.254 USD
3 years ago
Jun 09, 2021
Sell 56.8 K USD
PEIZER TERREN S
Executive Chairman
- 1530
 37.1482 USD
3 years ago
Jun 09, 2021
Sell 130 K USD
PEIZER TERREN S
Executive Chairman
- 3400
 38.2751 USD
3 years ago
Jun 09, 2021
Sell 70.4 K USD
PEIZER TERREN S
Executive Chairman
- 1800
 39.1306 USD
3 years ago
Jun 09, 2021
Sell 353 K USD
PEIZER TERREN S
Executive Chairman
- 8740
 40.3325 USD
3 years ago
Jun 09, 2021
Sell 121 K USD
PEIZER TERREN S
Executive Chairman
- 2954
 41.0671 USD
3 years ago
Jun 02, 2021
Sell 158 K USD
PEIZER TERREN S
Executive Chairman
- 5304
 29.8356 USD
3 years ago
Jun 02, 2021
Sell 90.1 K USD
PEIZER TERREN S
Executive Chairman
- 2900
 31.0752 USD
3 years ago
Jun 02, 2021
Sell 67.8 K USD
PEIZER TERREN S
Executive Chairman
- 2096
 32.3469 USD
3 years ago
Jun 02, 2021
Sell 22.9 K USD
PEIZER TERREN S
Executive Chairman
- 700
 32.7386 USD
3 years ago
Jun 03, 2021
Sell 245 K USD
PEIZER TERREN S
Executive Chairman
- 7696
 31.8082 USD
3 years ago
Jun 03, 2021
Sell 85.3 K USD
PEIZER TERREN S
Executive Chairman
- 2604
 32.7602 USD
3 years ago
Jun 03, 2021
Sell 23.4 K USD
PEIZER TERREN S
Executive Chairman
- 700
 33.4429 USD
3 years ago
Jun 04, 2021
Sell 208 K USD
PEIZER TERREN S
Executive Chairman
- 6737
 30.8942 USD
3 years ago
Jun 04, 2021
Sell 136 K USD
PEIZER TERREN S
Executive Chairman
- 4263
 31.8532 USD
3 years ago
May 27, 2021
Sell 325 K USD
PEIZER TERREN S
Executive Chairman
- 10800
 30.0592 USD
3 years ago
May 27, 2021
Sell 6.14 K USD
PEIZER TERREN S
Executive Chairman
- 200
 30.72 USD
3 years ago
May 28, 2021
Sell 236 K USD
PEIZER TERREN S
Executive Chairman
- 7703
 30.6614 USD
3 years ago
May 28, 2021
Sell 103 K USD
PEIZER TERREN S
Executive Chairman
- 3297
 31.3714 USD
3 years ago
Jun 01, 2021
Sell 328 K USD
PEIZER TERREN S
Executive Chairman
- 11000
 29.8415 USD
3 years ago
May 24, 2021
Sell 191 K USD
PEIZER TERREN S
Executive Chairman
- 6386
 29.9682 USD
3 years ago
May 24, 2021
Sell 143 K USD
PEIZER TERREN S
Executive Chairman
- 4614
 30.9639 USD
3 years ago
May 25, 2021
Sell 310 K USD
PEIZER TERREN S
Executive Chairman
- 10290
 30.0792 USD
3 years ago
May 25, 2021
Sell 21.8 K USD
PEIZER TERREN S
Executive Chairman
- 710
 30.7385 USD
3 years ago
May 26, 2021
Sell 311 K USD
PEIZER TERREN S
Executive Chairman
- 10300
 30.241 USD
3 years ago
May 26, 2021
Sell 21.5 K USD
PEIZER TERREN S
Executive Chairman
- 700
 30.7814 USD
3 years ago
May 19, 2021
Sell 334 K USD
PEIZER TERREN S
Executive Chairman
- 10868
 30.6926 USD
3 years ago
May 19, 2021
Sell 4.12 K USD
PEIZER TERREN S
Executive Chairman
- 132
 31.2 USD
3 years ago
May 20, 2021
Sell 129 K USD
PEIZER TERREN S
Executive Chairman
- 4130
 31.2715 USD
3 years ago
May 20, 2021
Sell 220 K USD
PEIZER TERREN S
Executive Chairman
- 6870
 32.0525 USD
3 years ago
May 21, 2021
Sell 300 K USD
PEIZER TERREN S
Executive Chairman
- 9390
 31.918 USD
3 years ago
May 21, 2021
Sell 52.2 K USD
PEIZER TERREN S
Executive Chairman
- 1610
 32.4179 USD
3 years ago
May 14, 2021
Sell 91.7 K USD
PEIZER TERREN S
Executive Chairman
- 3025
 30.3163 USD
3 years ago
May 14, 2021
Sell 69 K USD
PEIZER TERREN S
Executive Chairman
- 2200
 31.3543 USD
3 years ago
May 14, 2021
Sell 185 K USD
PEIZER TERREN S
Executive Chairman
- 5775
 32.0918 USD
3 years ago
May 17, 2021
Sell 263 K USD
PEIZER TERREN S
Executive Chairman
- 8200
 32.0381 USD
3 years ago
May 17, 2021
Sell 91.5 K USD
PEIZER TERREN S
Executive Chairman
- 2800
 32.6775 USD
3 years ago
May 18, 2021
Sell 258 K USD
PEIZER TERREN S
Executive Chairman
- 8077
 31.9981 USD
3 years ago
May 18, 2021
Sell 95 K USD
PEIZER TERREN S
Executive Chairman
- 2923
 32.4933 USD
3 years ago
May 11, 2021
Sell 31.6 K USD
PEIZER TERREN S
Executive Chairman
- 1099
 28.711 USD
3 years ago
May 11, 2021
Sell 100 K USD
PEIZER TERREN S
Executive Chairman
- 3401
 29.4705 USD
3 years ago
May 11, 2021
Sell 63.9 K USD
PEIZER TERREN S
Executive Chairman
- 2089
 30.5848 USD
3 years ago
May 11, 2021
Sell 85.4 K USD
PEIZER TERREN S
Executive Chairman
- 2700
 31.6293 USD
3 years ago
May 11, 2021
Sell 55.1 K USD
PEIZER TERREN S
Executive Chairman
- 1711
 32.218 USD
3 years ago
May 12, 2021
Sell 203 K USD
PEIZER TERREN S
Executive Chairman
- 6500
 31.2745 USD
3 years ago
May 12, 2021
Sell 144 K USD
PEIZER TERREN S
Executive Chairman
- 4500
 31.9578 USD
3 years ago
May 13, 2021
Sell 198 K USD
PEIZER TERREN S
Executive Chairman
- 6629
 29.9244 USD
3 years ago
May 13, 2021
Sell 39.5 K USD
PEIZER TERREN S
Executive Chairman
- 1271
 31.0727 USD
3 years ago
May 13, 2021
Sell 99 K USD
PEIZER TERREN S
Executive Chairman
- 3100
 31.9317 USD
3 years ago
May 11, 2021
Sell 31.6 K USD
PEIZER TERREN S
Executive Chairman
- 1099
 28.711 USD
3 years ago
May 11, 2021
Sell 100 K USD
PEIZER TERREN S
Executive Chairman
- 3401
 29.4705 USD
3 years ago
May 11, 2021
Sell 63.9 K USD
PEIZER TERREN S
Executive Chairman
- 2089
 30.5848 USD
3 years ago
May 11, 2021
Sell 85.4 K USD
PEIZER TERREN S
Executive Chairman
- 2700
 31.6293 USD
3 years ago
May 11, 2021
Sell 55.1 K USD
PEIZER TERREN S
Executive Chairman
- 1711
 32.218 USD
3 years ago
May 12, 2021
Sell 203 K USD
PEIZER TERREN S
Executive Chairman
- 6500
 31.2745 USD
3 years ago
May 12, 2021
Sell 144 K USD
PEIZER TERREN S
Executive Chairman
- 4500
 31.9578 USD
3 years ago
May 13, 2021
Sell 198 K USD
PEIZER TERREN S
Executive Chairman
- 6629
 29.9244 USD
3 years ago
May 13, 2021
Sell 39.5 K USD
PEIZER TERREN S
Executive Chairman
- 1271
 31.0727 USD
3 years ago
May 13, 2021
Sell 99 K USD
PEIZER TERREN S
Executive Chairman
- 3100
 31.9317 USD
3 years ago
May 10, 2021
Sell 337 K USD
PEIZER TERREN S
Executive Chairman
- 10887
 30.92 USD
3 years ago
May 10, 2021
Sell 2.4 M USD
PEIZER TERREN S
Executive Chairman
- 78685
 30.44 USD
8 years ago
Aug 15, 2016
Bought 2.39 M USD
PEIZER TERREN S
Executive Chairman
+ 498927
 4.8 USD
7 years ago
Jan 31, 2017
Bought 944 K USD
PEIZER TERREN S
Executive Chairman
+ 196707
 4.8 USD
4 years ago
Jul 29, 2020
Bought 337 K USD
PEIZER TERREN S
Executive Chairman
+ 187002
 1.8 USD
7 years ago
Feb 17, 2017
Bought 296 K USD
PEIZER TERREN S
Executive Chairman
+ 61765
 4.8 USD
7 years ago
Mar 28, 2017
Bought 235 K USD
PEIZER TERREN S
Executive Chairman
+ 49020
 4.8 USD
7 years ago
Apr 13, 2017
Bought 174 K USD
PEIZER TERREN S
Executive Chairman
+ 36275
 4.8 USD
4 years ago
Apr 09, 2020
Bought 104 K USD
Rebak Robert
Director
+ 5000
 20.7 USD
4 years ago
Apr 09, 2020
Bought 104 K USD
Rebak Robert
Director
+ 5000
 20.7 USD
4 years ago
Mar 24, 2020
Bought 33.1 K USD
Rebak Robert
Director
+ 3200
 10.33 USD
4 years ago
Mar 16, 2020
Bought 20 K USD
Medeiros Curtis
Chief Operating Officer
+ 1904
 10.5 USD
4 years ago
Mar 16, 2020
Bought 87 K USD
Medeiros Curtis
Chief Operating Officer
+ 7561
 11.5 USD
4 years ago
Mar 16, 2020
Bought 93 K USD
Medeiros Curtis
Chief Operating Officer
+ 8797
 10.5767 USD
4 years ago
Mar 23, 2020
Bought 22.5 K USD
Medeiros Curtis
Chief Operating Officer
+ 2335
 9.6395 USD
4 years ago
Mar 23, 2020
Bought 88.5 K USD
Medeiros Curtis
Chief Operating Officer
+ 9500
 9.3108 USD
4 years ago
Mar 23, 2020
Bought 89.1 K USD
Medeiros Curtis
Chief Operating Officer
+ 10000
 8.9079 USD
4 years ago
Mar 16, 2020
Bought 20 K USD
Medeiros Curtis
Chief Operating Officer
+ 1904
 10.5 USD
4 years ago
Mar 16, 2020
Bought 87 K USD
Medeiros Curtis
Chief Operating Officer
+ 7561
 11.5 USD
4 years ago
Mar 16, 2020
Bought 93 K USD
Medeiros Curtis
Chief Operating Officer
+ 8797
 10.5767 USD
4 years ago
Feb 06, 2020
Sell 15 K USD
Smith David E
- 796
 18.8437 USD
4 years ago
Feb 19, 2020
Sell 1.35 M USD
Smith David E
- 71852
 18.8023 USD
4 years ago
Feb 06, 2020
Sell 15 K USD
Smith David E
- 796
 18.8437 USD
4 years ago
Feb 05, 2020
Sell 475 K USD
Smith David E
- 25256
 18.7992 USD
5 years ago
May 15, 2019
Sell 779 K USD
Smith David E
- 42229
 18.445 USD
5 years ago
May 13, 2019
Sell 445 K USD
Smith David E
10 percent owner
- 24500
 18.1441 USD
5 years ago
May 14, 2019
Sell 183 K USD
Smith David E
10 percent owner
- 10000
 18.27 USD
5 years ago
May 09, 2019
Sell 279 K USD
Smith David E
10 percent owner
- 16192
 17.26 USD
5 years ago
May 10, 2019
Sell 9.12 K USD
Smith David E
10 percent owner
- 500
 18.24 USD
5 years ago
May 07, 2019
Sell 2.24 M USD
Smith David E
10 percent owner
- 136138
 16.4175 USD
5 years ago
May 08, 2019
Sell 479 K USD
Smith David E
10 percent owner
- 27893
 17.1642 USD
5 years ago
Apr 26, 2019
Sell 722 K USD
Smith David E
10 percent owner
- 45792
 15.7588 USD
5 years ago
Apr 29, 2019
Sell 80.3 K USD
Smith David E
10 percent owner
- 5023
 15.98 USD
5 years ago
Apr 24, 2019
Sell 862 K USD
Smith David E
10 percent owner
- 58984
 14.6091 USD
5 years ago
Apr 25, 2019
Sell 1.17 M USD
Smith David E
10 percent owner
- 76789
 15.2755 USD
5 years ago
Apr 11, 2019
Sell 1.37 K USD
Smith David E
10 percent owner
- 99
 13.88 USD
5 years ago
Apr 02, 2019
Sell 123 K USD
Smith David E
10 percent owner
- 8724
 14.05 USD
5 years ago
Apr 02, 2019
Sell 325 K USD
Smith David E
10 percent owner
- 23090
 14.09 USD
5 years ago
Mar 25, 2019
Sell 225 K USD
Smith David E
10 percent owner
- 16322
 13.8 USD
5 years ago
Mar 26, 2019
Sell 227 K USD
Smith David E
10 percent owner
- 16276
 13.92 USD
5 years ago
Mar 26, 2019
Sell 144 K USD
Smith David E
10 percent owner
- 10439
 13.84 USD
5 years ago
Mar 21, 2019
Sell 105 K USD
Smith David E
10 percent owner
- 7543
 13.95 USD
5 years ago
Mar 22, 2019
Sell 1.4 K USD
Smith David E
10 percent owner
- 100
 13.95 USD
5 years ago
Mar 19, 2019
Sell 73.4 K USD
Smith David E
10 percent owner
- 5176
 14.19 USD
5 years ago
Mar 19, 2019
Sell 221 K USD
Smith David E
10 percent owner
- 15596
 14.1915 USD
5 years ago
Mar 19, 2019
Sell 174 K USD
Smith David E
10 percent owner
- 12355
 14.1 USD
5 years ago
Mar 19, 2019
Sell 211 K USD
Smith David E
10 percent owner
- 14824
 14.2346 USD
5 years ago
Mar 15, 2019
Sell 159 K USD
Smith David E
10 percent owner
- 11175
 14.19 USD
5 years ago
Mar 18, 2019
Sell 232 K USD
Smith David E
10 percent owner
- 16470
 14.11 USD
6 years ago
Jun 15, 2018
Bought 1.84 K USD
GORLIN STEVE
Director
+ 215
 8.57 USD
6 years ago
Jun 15, 2018
Bought 19.8 K USD
GORLIN STEVE
Director
+ 2300
 8.59 USD
6 years ago
Jun 15, 2018
Bought 2.6 K USD
GORLIN STEVE
Director
+ 300
 8.65 USD
6 years ago
Jun 15, 2018
Bought 13.3 K USD
GORLIN STEVE
Director
+ 1550
 8.6 USD
6 years ago
Jun 15, 2018
Bought 864 USD
GORLIN STEVE
Director
+ 100
 8.64 USD
6 years ago
Jun 15, 2018
Bought 2.58 K USD
GORLIN STEVE
Director
+ 300
 8.59 USD
6 years ago
Jun 15, 2018
Bought 14.8 K USD
GORLIN STEVE
Director
+ 1700
 8.68 USD
6 years ago
Jun 15, 2018
Bought 2.59 K USD
GORLIN STEVE
Director
+ 300
 8.63 USD
6 years ago
Jun 15, 2018
Bought 6.08 K USD
GORLIN STEVE
Director
+ 700
 8.69 USD
6 years ago
Jun 15, 2018
Bought 26.1 K USD
GORLIN STEVE
Director
+ 3000
 8.7 USD
6 years ago
Jun 15, 2018
Bought 1.73 K USD
GORLIN STEVE
Director
+ 200
 8.67 USD
6 years ago
Jun 15, 2018
Bought 9.58 K USD
GORLIN STEVE
Director
+ 1100
 8.71 USD
6 years ago
Jun 15, 2018
Bought 863 USD
GORLIN STEVE
Director
+ 100
 8.63 USD
6 years ago
Jun 15, 2018
Bought 1.72 K USD
GORLIN STEVE
Director
+ 200
 8.58 USD
6 years ago
Jun 15, 2018
Bought 2.98 K USD
GORLIN STEVE
Director
+ 350
 8.5 USD
6 years ago
Jun 15, 2018
Bought 845 USD
GORLIN STEVE
Director
+ 100
 8.45 USD
6 years ago
Jun 15, 2018
Bought 11.8 K USD
GORLIN STEVE
Director
+ 1385
 8.49 USD
6 years ago
Jun 15, 2018
Bought 9.32 K USD
GORLIN STEVE
Director
+ 1100
 8.47 USD
6 years ago
Jun 15, 2018
Bought 976 USD
GORLIN STEVE
Director
+ 115
 8.49 USD
6 years ago
Jun 15, 2018
Bought 721 USD
GORLIN STEVE
Director
+ 85
 8.48 USD
6 years ago
Jun 15, 2018
Bought 7.61 K USD
GORLIN STEVE
Director
+ 900
 8.46 USD
6 years ago
Jun 15, 2018
Bought 1.69 K USD
GORLIN STEVE
Director
+ 200
 8.45 USD
6 years ago
Jun 15, 2018
Bought 5.1 K USD
GORLIN STEVE
Director
+ 600
 8.5 USD
6 years ago
Jun 15, 2018
Bought 1.69 K USD
GORLIN STEVE
Director
+ 200
 8.47 USD
6 years ago
Jun 15, 2018
Bought 841 USD
GORLIN STEVE
Director
+ 100
 8.41 USD
6 years ago
Jun 15, 2018
Bought 6.72 K USD
GORLIN STEVE
Director
+ 800
 8.4 USD
6 years ago
Jun 15, 2018
Bought 8.39 K USD
GORLIN STEVE
Director
+ 1000
 8.39 USD
6 years ago
Jun 15, 2018
Bought 838 USD
GORLIN STEVE
Director
+ 100
 8.38 USD
6 years ago
Jun 15, 2018
Bought 6.68 K USD
GORLIN STEVE
Director
+ 800
 8.35 USD
6 years ago
Jun 15, 2018
Bought 834 USD
GORLIN STEVE
Director
+ 100
 8.34 USD
6 years ago
Jun 15, 2018
Bought 2.38 K USD
GORLIN STEVE
Director
+ 300
 7.95 USD
6 years ago
Jun 15, 2018
Bought 9.49 K USD
GORLIN STEVE
Director
+ 1200
 7.91 USD
6 years ago
Jun 15, 2018
Bought 17.5 K USD
GORLIN STEVE
Director
+ 2200
 7.94 USD
6 years ago
Jun 15, 2018
Bought 4.75 K USD
GORLIN STEVE
Director
+ 600
 7.91 USD
6 years ago
Jun 15, 2018
Bought 4.76 K USD
GORLIN STEVE
Director
+ 600
 7.93 USD
6 years ago
Jun 15, 2018
Bought 792 USD
GORLIN STEVE
Director
+ 100
 7.92 USD
6 years ago
Mar 13, 2018
Bought 29 K USD
Sherman Michael Edward
Director
+ 6000
 4.83 USD
6 years ago
Mar 13, 2018
Bought 12 K USD
Sherman Michael Edward
Director
+ 2500
 4.8 USD
6 years ago
Mar 13, 2018
Bought 5.77 K USD
Sherman Michael Edward
Director
+ 1210
 4.77 USD
6 years ago
Mar 13, 2018
Bought 2.9 K USD
Sherman Michael Edward
Director
+ 609
 4.76 USD
6 years ago
Mar 13, 2018
Bought 4.15 K USD
Sherman Michael Edward
Director
+ 873
 4.75 USD
6 years ago
Mar 13, 2018
Bought 275 USD
Sherman Michael Edward
Director
+ 58
 4.74 USD
6 years ago
Mar 12, 2018
Bought 8.59 K USD
Sherman Michael Edward
Director
+ 1800
 4.77 USD
6 years ago
Mar 12, 2018
Bought 7.14 K USD
Sherman Michael Edward
Director
+ 1500
 4.76 USD
6 years ago
Mar 12, 2018
Bought 4.75 K USD
Sherman Michael Edward
Director
+ 1000
 4.75 USD
7 years ago
Apr 28, 2017
Bought 870 K USD
PEIZER TERREN S
Chairman & CEO
+ 181154
 4.8 USD
8 years ago
Aug 15, 2016
Bought 78.8 K USD
PEIZER TERREN S
Chairman & CEO
+ 71591
 1.1 USD
9 years ago
Jul 30, 2015
Bought 0 USD
PEIZER TERREN S
Chairman & CEO
+ 0
 1.9 USD
9 years ago
Jul 30, 2015
Bought 1.78 M USD
PEIZER TERREN S
Chairman & CEO
+ 935008
 1.9 USD
8 years ago
Mar 30, 2016
Bought 212 K USD
PEIZER TERREN S
Chairman & CEO
+ 450000
 0.47 USD
8 years ago
Jul 05, 2016
Bought 105 K USD
PEIZER TERREN S
Chairman & CEO
+ 318182
 0.33 USD
8 years ago
May 24, 2016
Bought 101 K USD
PEIZER TERREN S
Chairman & CEO
+ 306818
 0.33 USD
8 years ago
Apr 27, 2016
Bought 94 K USD
PEIZER TERREN S
Chairman & CEO
+ 200000
 0.47 USD
8 years ago
Jun 22, 2016
Bought 62.5 K USD
PEIZER TERREN S
Chairman & CEO
+ 189394
 0.33 USD
8 years ago
Jun 02, 2016
Bought 57.5 K USD
PEIZER TERREN S
Chairman & CEO
+ 174242
 0.33 USD
8 years ago
Jul 21, 2016
Bought 37.5 K USD
PEIZER TERREN S
Chairman & CEO
+ 113636
 0.33 USD
9 years ago
Oct 16, 2015
Bought 287 K USD
Smith David E
director, 10 percent owner:
+ 956667
 0.3 USD
9 years ago
Oct 16, 2015
Bought 90 K USD
GORLIN STEVE
Director
+ 300000
 0.3 USD
9 years ago
Oct 16, 2015
Bought 1.62 M USD
PEIZER TERREN S
Chairman & CEO
+ 5410000
 0.3 USD
9 years ago
Sep 17, 2015
Bought 463 K USD
PEIZER TERREN S
Chairman & CEO
+ 1543334
 0.3 USD
9 years ago
Dec 22, 2014
Bought 300 K USD
GORLIN STEVE
Director
+ 150000
 2 USD
9 years ago
Dec 23, 2014
Bought 140 K USD
PEIZER TERREN S
Chairman & CEO
+ 70000
 2 USD
10 years ago
May 27, 2014
Bought 200 K USD
Smith David E
10 percent owner
+ 344828
 0.58 USD
10 years ago
May 27, 2014
Bought 200 K USD
Smith David E
10 percent owner
+ 344828
 0.58 USD
10 years ago
May 27, 2014
Bought 1.21 M USD
PEIZER TERREN S
Chairman & CEO
+ 2077587
 0.58 USD
10 years ago
May 27, 2014
Bought 1.21 M USD
PEIZER TERREN S
Chairman & CEO
+ 2077587
 0.58 USD
10 years ago
Jan 31, 2014
Bought 920 K USD
PEIZER TERREN S
Chairman & CEO
+ 1585345
 0.58 USD
10 years ago
Jan 31, 2014
Bought 920 K USD
PEIZER TERREN S
Chairman & CEO
+ 1585345
 0.58 USD
11 years ago
Oct 15, 2013
Bought 500 K USD
Smith David E
10 percent owner
+ 862069
 0.58 USD
11 years ago
Oct 15, 2013
Bought 500 K USD
Smith David E
10 percent owner
+ 862069
 0.58 USD
11 years ago
Oct 15, 2013
Bought 2 M USD
PEIZER TERREN S
Chairman & CEO
+ 3448276
 0.58 USD
11 years ago
Oct 15, 2013
Bought 2 M USD
PEIZER TERREN S
Chairman & CEO
+ 3448276
 0.58 USD
11 years ago
Apr 10, 2013
Bought 228 K USD
Smith David E
10 percent owner
+ 3257143
 0.07 USD
11 years ago
Apr 10, 2013
Bought 228 K USD
Smith David E
10 percent owner
+ 3257143
 0.07 USD
11 years ago
Apr 10, 2013
Bought 1.21 M USD
PEIZER TERREN S
Chairman & CEO
+ 17300000
 0.07 USD
11 years ago
Apr 10, 2013
Bought 1.21 M USD
PEIZER TERREN S
Chairman & CEO
+ 17300000
 0.07 USD
11 years ago
Dec 04, 2012
Bought 2.5 M USD
PEIZER TERREN S
Chairman & CEO
+ 35714286
 0.07 USD
11 years ago
Dec 04, 2012
Bought 2.5 M USD
PEIZER TERREN S
Chairman & CEO
+ 35714286
 0.07 USD
11 years ago
Dec 04, 2012
Bought 500 K USD
Smith David E
10 percent owner
+ 7142858
 0.07 USD
12 years ago
Sep 13, 2012
Bought 981 K USD
PEIZER TERREN S
Chairman & CEO
+ 9810000
 0.1 USD
12 years ago
Sep 13, 2012
Bought 981 K USD
PEIZER TERREN S
Chairman & CEO
+ 9810000
 0.1 USD
12 years ago
Apr 17, 2012
Bought 1.75 M USD
PEIZER TERREN S
Chairman & CEO
+ 10965050
 0.16 USD
12 years ago
Apr 17, 2012
Bought 1.75 M USD
PEIZER TERREN S
Chairman & CEO
+ 10965050
 0.16 USD
12 years ago
Dec 27, 2011
Bought 166 K USD
PEIZER TERREN S
Chairman & CEO
+ 553290
 0.3 USD
12 years ago
Dec 28, 2011
Sell 118 K USD
PEIZER TERREN S
Chairman & CEO
- 393334
 0.3 USD
12 years ago
Dec 27, 2011
Bought 166 K USD
PEIZER TERREN S
Chairman & CEO
+ 553290
 0.3 USD
12 years ago
Dec 28, 2011
Sell 118 K USD
PEIZER TERREN S
Chairman & CEO
- 393334
 0.3 USD
12 years ago
Dec 08, 2011
Bought 55.4 K USD
PEIZER TERREN S
Chairman & CEO
+ 173077
 0.32 USD
12 years ago
Dec 08, 2011
Bought 0 USD
PEIZER TERREN S
Chairman & CEO
+ 0
 0.26 USD
12 years ago
Feb 22, 2012
Bought 0 USD
PEIZER TERREN S
Chairman & CEO
+ 0
 0.3 USD
12 years ago
Feb 22, 2012
Bought 975 K USD
PEIZER TERREN S
Chairman & CEO
+ 3250000
 0.3 USD
12 years ago
Nov 30, 2011
Bought 0 USD
PEIZER TERREN S
Chairman & CEO
+ 0
 0.26 USD
12 years ago
Nov 30, 2011
Bought 289 K USD
PEIZER TERREN S
Chairman & CEO
+ 903847
 0.32 USD
13 years ago
Nov 15, 2011
Bought 0 USD
PEIZER TERREN S
Chairman & CEO
+ 0
 0.26 USD
13 years ago
Nov 15, 2011
Bought 197 K USD
PEIZER TERREN S
Chairman & CEO
+ 615385
 0.32 USD
13 years ago
Nov 02, 2011
Bought 197 K USD
PEIZER TERREN S
Chairman & CEO
+ 615385
 0.32 USD
13 years ago
Nov 02, 2011
Bought 0 USD
PEIZER TERREN S
Chairman & CEO
+ 0
 0.26 USD
13 years ago
Aug 17, 2011
Bought 800 K USD
PEIZER TERREN S
Chairman & CEO
+ 2500000
 0.32 USD
13 years ago
Aug 17, 2011
Bought 0 USD
PEIZER TERREN S
Chairman & CEO
+ 0
 0.26 USD
13 years ago
Sep 02, 2011
Bought 80 USD
Smith David E
10 percent owner
+ 250
 0.32 USD
13 years ago
Sep 01, 2011
Bought 146 USD
Smith David E
10 percent owner
+ 457
 0.32 USD
13 years ago
Mar 17, 2011
Bought 1.78 M USD
Smith David E
10 percent owner
+ 4452081
 0.4 USD
13 years ago
Oct 05, 2011
Bought 0.26 USD
Smith David E
10 percent owner
+ 1
 0.26 USD
13 years ago
Oct 05, 2011
Bought 0.32 USD
Smith David E
10 percent owner
+ 1
 0.32 USD
13 years ago
Oct 05, 2011
Bought 0.26 USD
Smith David E
10 percent owner
+ 1
 0.26 USD
13 years ago
Oct 05, 2011
Bought 0.32 USD
Smith David E
10 percent owner
+ 1
 0.32 USD
14 years ago
Nov 12, 2010
Bought 171 K USD
Wolf Jay
Director
+ 17121585
 0.01 USD
14 years ago
Nov 12, 2010
Bought 28.8 K USD
Wolf Jay
Director
+ 2878415
 0.01 USD
7. News
Ontrak, Inc. (OTRK) Q3 2024 Earnings Call Transcript Ontrak, Inc. (NASDAQ:OTRK ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations, Gilmartin Group Brandon LaVerne - Chief Executive Officer & Chief Operating Officer Mary Lou Osborne - President & Chief Commercial Officer James Park - Chief Financial Officer Conference Call Participants Operator Thank you for standing by. Welcome to the Ontrak Health Third Quarter 2024 Earnings Call. seekingalpha.com - 3 days ago
Ontrak, Inc. (OTRK) Reports Q3 Loss, Lags Revenue Estimates Ontrak, Inc. (OTRK) came out with a quarterly loss of $1.77 per share versus the Zacks Consensus Estimate of a loss of $1.56. This compares to loss of $24.14 per share a year ago. zacks.com - 3 days ago
Ontrak Health Announces 2024 Third Quarter Financial Results MIAMI--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and technology-enabled behavioral healthcare company, today reported its financial results for the third quarter ended September 30, 2024. Management Commentary Brandon LaVerne, Ontrak Health's Chief Executive Officer, stated, “I am thrilled that we have now secured two new regional health plan customers and four health plan expansions since January of this year, spanning a range of plan types,. businesswire.com - 3 days ago
Ontrak, Inc. (OTRK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Ontrak (OTRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 1 week ago
Ontrak Health Expands Behavioral Health Solutions with Sentara Health Plans for Commercial and Marketplace Populations MIAMI--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled behavioral healthcare company, today announced a continuing expansion of its strategic partnership with Sentara Health Plans in the Commonwealth of Virginia. Ontrak is thrilled to be expanding services with Sentara Health Plans, the health plan division of Sentara Health, an integrated, not-for-profit health care delivery system. This expansion represents a dual expansion of its Engage solution, a c. businesswire.com - 1 week ago
Ontrak Health to Report 2024 Third Quarter Financial Results on November 13, 2024 MIAMI--(BUSINESS WIRE)--Ontrak Health (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in inf. businesswire.com - 2 weeks ago
Ontrak Announces Receipt of Notice from Nasdaq Regarding Non-Compliance of its 9.50% Series A Cumulative Perpetual Preferred Stock with Minimum Bid Price Requirement HENDERSON, Nev.--(BUSINESS WIRE)--On April 13, 2023, Ontrak, Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5555(a)(1) (the “Minimum Bid Price Requirement”) because the closing bid price for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Preferred Stock”) was less than $1.00 for the previous 30 consecutive business days. The Notice has no immediate effect on the listing of the Company’s Preferred Stock on The Nasdaq Global Market. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a 180-calendar day grace period, or until October 10, 2023 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. The Minimum Bid Price Requirement will be met if the Company’s Preferred Stock has a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during the 180-calendar day grace period, unless Nasdaq exercises its discretion to extend such 10-day period. If the Company does not regain compliance by the Compliance Date, the Company may be eligible for an additional 180-calendar day compliance period, subject to satisfying the conditions in the applicable Nasdaq Listing Rules. The Company is monitoring the closing bid price of its Preferred Stock and will consider options to regain compliance with the Minimum Bid Price Requirement. However, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” About Ontrak, Inc. Ontrak, Inc. is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. businesswire.com - 1 year ago
Ontrak Announces Receipt of Notice from Nasdaq Regarding Non-Compliance of its 9.50% Series A Cumulative Perpetual Preferred Stock with Minimum Bid Price Requirement HENDERSON, Nev.--(BUSINESS WIRE)--(NASDAQ: OTRK) (NASDAQ: OTRKP) – On December 6, 2022, Ontrak, Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer meets the minimum bid price requirement set forth in Nasdaq Listing Rule 5460(a)(3) (the “Minimum Bid Price Requirement”) because the closing bid price for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Preferred Stock”) was less than $1.00 for the previous 30 consecutive business days. The Notice has no immediate effect on the listing of the Preferred Stock on The Nasdaq Global Market. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a 180-calendar day grace period, or until June 5, 2023 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. The Minimum Bid Price Requirement will be met if the Preferred Stock has a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during the 180-calendar day grace period, unless Nasdaq exercises its discretion to extend such 10-day period. If the Company does not regain compliance by the Compliance Date, the Company may be eligible for an additional 180-calendar day compliance period, subject to satisfying the conditions in the applicable Nasdaq Listing Rules. The Company is monitoring the closing bid price of the Preferred Stock and will consider options to regain compliance with the Minimum Bid Price Requirement. However, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” About Ontrak, Inc. Ontrak, Inc. is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. Learn more at www.ontrakhealth.com. businesswire.com - 1 year ago
Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (NASDAQ: OTRKP) (“Ontrak” or the “Company”) today announced that its Board of Directors has declared the fifth quarterly cash dividend for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). The fifth quarterly cash dividend equals $0.593750 per share, at 9.50% per annum of liquidation preference of $25.00 per share. The Series A Preferred Stock dividend will be payable on November 30, 2021 to holders of record as of the close of business on November 15, 2021, provided that if any dividend payment date is not a business day, then the dividend that would otherwise have been payable may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after the dividend payment date to that next succeeding business day. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” For additional information, visit https://www.ontrakhealth.com. About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. Learn more at www.ontrakhealth.com businesswire.com - 3 years ago
Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (NASDAQ: OTRKP) (“Ontrak” or the “Company”) today announced that its Board of Directors has declared the fourth quarterly cash dividend for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). The fourth quarterly cash dividend equals $0.593750 per share, at 9.50% per annum of liquidation preference of $25.00 per share. The Series A Preferred Stock dividend will be payable on August 31, 2021 to holders of record as of the close of business on August 15, 2021, provided that if any dividend payment date is not a business day, then the dividend that would otherwise have been payable may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after the dividend payment date to that next succeeding business day. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” For additional information, visit https://www.ontrak-inc.com. About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors. Learn more at www.ontrak-inc.com. businesswire.com - 3 years ago
Ontrak Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (NASDAQ: OTRKP) (“Ontrak” or the “Company”) today announced that its Board of Directors has declared the third quarterly cash dividend for the Company’s 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”). The third quarterly cash dividend equals $0.593750 per share, at 9.50% per annum of liquidation preference of $25.00 per share. The Series A Preferred Stock dividend will be payable on May 30, 2021 to holders of record as of the close of business on May 15, 2021, provided that if any dividend payment date is not a business day, then the dividend that would otherwise have been payable may be paid on the next succeeding business day and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after the dividend payment date to that next succeeding business day. The Series A Preferred Stock trades on NASDAQ Global Market under the symbol “OTRKP.” For additional information, visit https://www.ontrak-inc.com About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth enabled, virtualized healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The company’s PRE™ (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who are not getting the care they need. By combining predictive analytics with human engagement, Ontrak delivers improved member health and validated outcomes and savings to healthcare payers. The company’s integrated, technology-enabled Ontrak™ programs, a critical component of the PRE platform, are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Ontrak has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance. Ontrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The company’s programs improve member health and deliver validated cost savings to healthcare payers of between 40 and 50 percent of enrolled members. Learn more at www.ontrak-inc.com businesswire.com - 3 years ago
Ontrak Announces 2020 Fourth Quarter and Year End Financial Results SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today reported its financial results for the fourth quarter and year ended December 31, 2020. Management Commentary “While we are extremely disappointed by the upcoming loss of our Ontrak-A contract in June 2021, we are focused on the growth opportunities ahead of us with existing and new customers," said Terren Peizer, Ontrak Chairman and CEO. “During the fourth quarter, expanded programs with existing health plans and signed contract renewals with current customers resulted in strong enrollment rates which we expect to see continue through 2021. The tailwinds to our financial performance as we enter 2021 are: Very rapid enrollment of members under our Ontrak-CI contract, which expanded in October 2020 and already tops 5,100 members. A severe shortage of quality behavioral health providers which has heightened the value of our contractual relationships with over 11,600 high quality behavioral health providers whom we train and from whom we receive valuable member progress reports. We anticipate this number to grow to approximately 15,000 in Q2, resulting in the largest qualified behavioral health provider network in the industry. Continued momentum in our pipeline and expansions driven by health plan customer confidence in our member engagement, evidence-based care programs and proven savings and associated ROI. Our other existing customers besides Ontrak-A have either already signed extensions or expansions with us, or are expected to in the next month. Record high member satisfaction levels demonstrated by an industry leading Q4 2020 Net Promoter Score of 80 for our Ontrak program versus an NPS of 74 in Q3 2020. The anticipated 2021 launch of Ontrak tiered care programs for the full spectrum of behavioral health needs from high to low acuity, designed to meet 100% of the behavioral health needs of those with undiagnosed and untreated behavioral health conditions. The anticipated 2021 launch of an expanded suite of digital programs including mobile-first depression and anxiety modules that build upon the LifeDojo platform and scale our ability to serve more members in the rapidly growing behavioral health marketplace. Recently signed contract expansions for LifeDojo solutions with a subsidiary of Berkshire Hathaway and Dolby.” Mr. Peizer continued, “As a market leader in telemental health with a high-quality network of over 11,600 behavioral health provider contractual relationships in 40 states plus Washington DC, Ontrak is uniquely positioned to deliver positive and durable outcomes for not only care avoidant but also care neutral and care seeking members of our health plan partners. We have a total addressable market opportunity of over $30 billion.” Fourth Quarter 2020 Financial Results Highlights Revenue for the fourth quarter of 2020 was $29.3 million, representing a 149% increase compared to the same period in 2019 and a 22% increase from the prior quarter. Operating loss for the fourth quarter of 2020 was $(1.8) million, yielding an operating loss margin of (6)% compared to an operating loss of $(7.0) million for the same period in 2019, yielding an operating loss margin of (60)%. Operating loss improved 39% from an operating loss of $(3.0) million in the third quarter of 2020. Adjusted EBITDA for the fourth quarter of 2020 was $2.2 million compared to adjusted EBITDA of $(4.6) million for the same period in 2019. Adjusted EBITDA improved sequentially by an average of $1.7 million in each of the quarters in 2020. Net loss for the fourth quarter of 2020 was $(3.2) million, or a $(0.27) diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to net loss of $(8.7) million, or a $(0.52) diluted net loss per share for the same period in 2019. Net loss and diluted net loss per common share improved 43% and 25% from net loss of $(5.7) million and $(0.36) diluted net loss per share in the third quarter of 2020, respectively. Non-GAAP net income for the fourth quarter of 2020 was $0.3 million, or a $(0.07) non-GAAP diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to non-GAAP net loss of $(6.4) million, or a $(0.39) non-GAAP diluted net loss per share for the same period in 2019. Non-GAAP net loss and non-GAAP diluted net loss per common share improved 109% and 65% from $(2.9) million non-GAAP net loss and $(0.20) non-GAAP diluted net loss per common share in the third quarter of 2020, respectively. Fiscal Year 2020 Financial Results Highlights Revenue for the full year of 2020 was $82.8 million, representing a 136% increase from prior year. Operating loss for the full year of 2020 was $(14.9) million, yielding an operating loss margin of (18)% compared to an operating loss of $(20.0) million for the prior year, yielding an operating loss margin of (57)%. Adjusted EBITDA for the full year of 2020 was $(4.3) million compared to adjusted EBITDA of $(12.9) million for the prior year. Net loss for the full year of 2020 was $(22.7) million, or a $(1.44) diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to net loss of $(25.7) million, or a $(1.56) diluted net loss per share for the prior year. Non-GAAP net loss for the full year of 2020 was $(12.0) million, or a $(0.82) non-GAAP diluted net loss per common share (after deduction for declared and undeclared preferred stock dividends), compared to non-GAAP net loss of $(18.9) million, or a $(1.15) non-GAAP diluted net loss per share for the prior year. Fourth Quarter 2020 and Recent Operating Highlights: Total enrolled members, including Ontrak-A members, increased to 15,702 at the end of Q4 2020 and to 15,524 as of the date of this release. Gross enrollment for the two-month period ended February 28, 2021, excluding the Ontrak-A customer, was 2,683, reflecting a 60% annualized enrollment rate. The Company renewed its contract with one of the nation's leading health insurance providers for its Ontrak-C solution in Texas. The Company launched Ontrak-CI Program for a national health plan in 13 states for the three-year contract awarded in June. The Company launched a new 3-year partnership with the Veterans Health Administration to transform suicide prevention care in the U.S. The Company raised $44.9 million ($41.4 million net of underwriting fees and other offering expenses) through the issuance of 1,815,265 of 9.50% Series A Cumulative Perpetual Preferred Stock ("Series A Preferred Stock"). The non-convertible Series A Preferred Stock trades on the Nasdaq Global Market under the symbol "OTRKP." The Company's Board of Directors appointed Robert I. Newton as its General Counsel and Secretary. Financial Outlook The following outlook is based on information available as of the date of this press release and is subject to change in the future. This outlook solely represents existing and planned enrollment launches, and program expansions with current health plan partners. For the year ending December 31, 2021, the Company provides the following outlook: Revenue of $100 million. Initially, we were going to guide to 100% growth with revenues of $165 million. In light of Ontrak-A, we believe we are being conservative with our $100 million revenue guidance. Of that number, over $88 million is from customers with existing contracts or in the signature phase and those health plan partners remaining with us are already contemplating further expansions. Moreover, we see tremendous upside with large plans in our pipeline. Furthermore, we are continuing to develop our strategy to regain the Ontrak-A business emphasizing our validated medical cost savings and ROI, our NPS of 80, and our clinical outcomes. Conference Call & Webcast Details The Company will host a conference call/webcast today at 4:30 pm ET/1:30 pm PT. Investors, analysts, employees and the general public can access the call by dialing (833) 519-1269 for U.S. participants or (914) 800-3841 for international participants, and referencing conference ID #4174875. A live and archived webcast of the event will be available at https://www.ontrak-inc.com/investors.html. About Ontrak, Inc. Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth enabled, virtualized healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The company’s PRE™ (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who are not getting the care they need. By combining predictive analytics with human engagement, Ontrak delivers improved member health and validated outcomes and savings to healthcare payers. The company’s integrated, technology-enabled Ontrak™ programs, a critical component of the PRE platform, are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Ontrak has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance. Ontrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The company’s programs improve member health and deliver validated cost savings to healthcare payers of between 40 and 50 percent for enrolled members. Learn more at www.ontrak-inc.com Forward-Looking Statements Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward looking statements may include for example statements regarding: growth and market opportunities; expansions with existing customers for new contracts and renewals; rapid enrollment rates; tailwinds, including statements of our expectations related to rapid enrollment under our Ontrak-CI contract, growth in, and value of, our provider contractual relationships, momentum in our pipeline and expansions and related health plan customers’ confidence in our programs and proven savings and associated ROI, the effect of our record high member satisfaction levels, the anticipated 2021 launch of our Ontrak tiered care programs and their ability to meet the needs of 100% of those with undiagnosed and untreated behavioral health conditions, the anticipated 2021 launch of an expanded suite of behavioral health programs and their scalability to serve more members, and recently signed contract expansions for our LifeDojo solutions; and statements regarding revenue growth in 2021 and our strategy to regain the Ontrak-A business. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations; limited operating history; our inability to execute our business plan; increase our revenue and achieve profitability; lower than anticipated eligible members under our contracts; our inability to recognize revenue; lack of outcomes and statistically significant formal research studies; difficulty enrolling new members and maintaining existing members in our programs; the risk that the treatment programs might not be effective; difficulty in developing, exploiting and protecting proprietary technologies; intense competition and substantial regulation in the health care industry; business disruption and related risks resulting from the outbreak of the novel coronavirus 2019; high customer concentration; dependence on key personnel and the ability to recruit, retain and develop a large and diverse workforce; the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern; our ability to raise additional capital when needed and our liquidity; and risks related to our ability to realize the potential benefits of and to effectively integrate acquisitions. You are urged to consider statements that include the words “may,” “will,” “could,” “should,” “believes,” “estimates,” “projects,” “potential,” “expects,” “plan,” “anticipates,” “intends,” “continues,” “forecast,” “designed,” “goal,” or the negative of those words or other comparable words to be uncertain and forward-looking. Forward looking statements may include statements regarding potential additional spending on behavioral health, our path towards profitability, our momentum, anticipation of 2020 headwinds becoming 2021 tailwinds, surging demand for “telemental” health services, revenue from new launches, nationwide contracts upon which to expand, significant progress towards contracting with our increasing pipeline of potential partners, our confidence in our growth strategy for 2021 and beyond, and our outlook for future revenues and Adjusted EBITDA. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at http://www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Non-GAAP Financial Measures To supplement its consolidated financial statements, which are prepared and presented in accordance with U.S. generally accepted accounting principles, or GAAP, the Company has provided in this press release and the quarterly conference call held on the date hereof certain non-GAAP financial measures. The non-GAAP financial measures presented include EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net loss, and Non-GAAP net loss per common share, which are not U.S. GAAP financial measures, and clarifies and enhances an understanding of our past performance. We believe that the presentation of these financial measures enhances an investor’s understanding of our financial performance. We further believe that these financial measures are useful financial metrics to assess our operating performance from period-to-period by excluding certain items that we believe are not representative of our core business. EBITDA consists of net loss before interest, taxes, depreciation and amortization expenses. Adjusted EBITDA consists of net loss before interest, taxes, depreciation, amortization, stock-based compensation, acquisition related costs, (gain) loss on change in fair value of warrant liability and write-off of debt issuance costs. We believe that making such adjustments provides investors meaningful information to understand our results of operations and the ability to analyze our financial and business trends on a period-to-period basis. Non-GAAP net loss consists of net loss adjusted for stock-based compensation, acquisition related costs, (gain) loss on change in fair value of warrant liability and write-off of debt issuance costs. Non-GAAP net loss per common share consists of loss per share adjusted for non-GAAP net loss attributable to common stockholders. We believe that making such adjustments provides investors meaningful information to understand our results of operations and the ability to analyze our financial and business trends on a period-to-period basis. We believe the above non-GAAP financial measures are commonly used by investors to evaluate our performance and that of our competitors. However, our use of the term EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net loss and Non-GAAP net loss per common share may vary from that of others in our industry. Neither EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net loss nor Non-GAAP net loss per common share should be considered as an alternative to net loss before taxes, net loss, net loss per common share or any other performance measures derived in accordance with U.S. GAAP as measures of performance. ONTRAK, INC. Consolidated Statements of Operations (in thousands, except per share data) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Revenue $ 29,251 $ 11,758 $ 82,837 $ 35,095 Cost of revenue 13,426 6,897 43,603 20,408 Gross profit 15,825 4,861 39,234 14,687 Operating expenses: Research and development 4,908 1,463 12,923 5,439 Sales and marketing 1,423 1,286 4,525 4,735 General and administrative 11,318 9,109 36,709 24,527 Total operating expenses 17,649 11,858 54,157 34,701 Operating loss (1,824 ) (6,997 ) (14,923 ) (20,014 ) Other income (expense), net 13 (21 ) (1,213 ) (2,598 ) Interest expense, net (2,063 ) (1,665 ) (7,219 ) (3,047 ) Loss before income taxes (3,874 ) (8,683 ) (23,355 ) (25,659 ) Income tax benefit 645 — 645 — Net loss (3,229 ) (8,683 ) (22,710 ) (25,659 ) Dividends on preferred stock - declared and undeclared (1,523 ) — (1,987 ) — Net loss attributable to common stockholders $ (4,752 ) $ (8,683 ) $ (24,697 ) $ (25,659 ) Net loss per common share - basic and diluted $ (0.27 ) $ (0.52 ) $ (1.44 ) $ (1.56 ) Weighted-average common shares outstanding - basic and diluted 17,472 16,590 17,112 16,418 ONTRAK, INC. Consolidated Balance Sheets (in thousands, except share and per share data) December 31, 2020 2019 Assets Current assets: Cash and cash equivalents $ 86,907 $ 13,610 Restricted cash - current 9,127 — Receivables, net 16,682 3,615 Unbilled receivables 4,426 2,093 Deferred costs - current 2,352 341 Prepaid expenses and other current assets 4,144 733 Total current assets 123,638 20,392 Long-term assets: Property and equipment, net 2,273 528 Restricted cash - long-term 7,176 408 Goodwill 5,727 — Intangible assets, net 3,561 — Other assets 367 112 Operating lease right-of-use asset 1,959 2,415 Total assets $ 144,701 $ 23,855 Liabilities and stockholders' equity (deficit) Current liabilities: Accounts payable $ 1,287 $ 1,385 Accrued compensation and benefits 4,723 3,640 Deferred revenue 20,954 5,803 Current portion of operating lease liability 434 374 Other accrued liabilities 9,012 2,205 Warrant liabilities — 691 Total current liabilities 36,410 14,098 Long-term liabilities: Long-term debt, net 45,719 31,597 Long-term operating lease liability 1,403 1,836 Long-term finance lease liabilities 418 233 Total liabilities 83,950 47,764 Commitments and contingencies Stockholders' deficit: Preferred stock, $0.0001 par value; 50,000,000 shares authorized; 3,770,265 and no shares issued and outstanding at December 31, 2020 and 2019, respectively — — Common stock, $0.0001 par value, 500,000,000 shares authorized; 17,543,218 and 16,616,165 shares issued and outstanding at December 31, 2020 and 2019, respectively 2 2 Additional paid-in capital 414,773 307,403 Accumulated deficit (354,024 ) (331,314 ) Total stockholders' equity (deficit) 60,751 (23,909 ) Total liabilities and stockholders' equity (deficit) $ 144,701 $ 23,855 ONTRAK, INC. Consolidated Statements of Cash Flows (in thousands ) Year Ended December 31, 2020 2019 Cash flows from operating activities Net loss $ (22,710 ) $ (25,659 ) Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation expense 8,126 5,210 Write-off of debt issuance costs — 1,505 Paid-in-kind interest expense 3,500 — Depreciation 303 133 Amortization 1,624 696 Deferred taxes (654 ) — Warrants issued for services — 43 Change in fair value of warrants 1,233 60 Change in fair value of contingent consideration (20 ) — 401(k) employer match in common shares 691 — Deferred rent — (26 ) Changes in operating assets and liabilities: Receivables (13,014 ) (2,233 ) Unbilled receivables (2,333 ) (2,093 ) Prepaid and other assets (5,677 ) (246 ) Accounts payable (175 ) 888 Deferred revenue 15,057 1,608 Lease liabilities (373 ) 684 Other accrued liabilities 8,140 2,529 Net cash used in operating activities (6,282 ) (16,901 ) Cash flows from investing activities Purchases of property and equipment (1,757 ) — Acquisition of LifeDojo, net of cash acquired (2,881 ) — Net cash used in investing activities (4,638 ) — Cash flows from financing activities Proceeds from issuance of preferred stock 87,359 — Preferred stock issuance costs (806 ) — Dividends paid (1,241 ) — Proceeds from revolving loan — 7,500 Repayment of revolving loan — (15,000 ) Proceeds from A/R facility — 36,527 Repayment of A/R facility — (1,938 ) Proceeds from loan 10,000 1,938 Debt issuance costs (128 ) (2,813 ) Debt termination related fees — (1,956 ) Proceed from warrant exercise 133 1,128 Proceed from options exercise 6,171 1,894 Finance lease obligations (186 ) 69 Financed insurance premium payments (1,190 ) — Net cash provided by financing activities 100,112 27,349 Net change in cash and restricted cash 89,192 10,448 Cash and restricted cash at beginning of period 14,018 3,570 Cash and restricted cash at end of period $ 103,210 $ 14,018 Supplemental disclosure of cash flow information: Interest paid $ 2,961 $ 870 Right of use asset obtained in exchange for lease obligation — 2,574 Non-cash financing and investing activities: Stock issued in acquisition of LifeDojo $ 5,035 $ — Financed insurance premiums 3,344 — Warrant issued in connection with 2024 Note — 2,354 Reclassification of warrant liability to equity 1,924 86 Finance lease and accrued purchases of property and equipment 500 250 Contingent consideration and cash holdback relating to acquisition of LifeDojo 605 — ONTRAK, INC. Reconciliation of Non-GAAP Measures (in thousands, except per share data) Reconciliation of Operating Loss to EBITDA and Adjusted EBITDA Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Operating Loss $ (1,824 ) $ (6,997 ) $ (14,923 ) $ (20,014 ) Depreciation expense 125 25 303 133 Amortization expense (1) 392 138 874 246 EBITDA (1,307 ) (6,834 ) (13,746 ) (19,635 ) Stock-based compensation expense 2,327 2,263 8,126 5,210 Write-off of debt issuance costs (2) — — — 1,505 Acquisition related costs (3) 1,153 — 1,329 — Adjusted EBITDA $ 2,173 $ (4,571 ) $ (4,291 ) $ (12,920 ) Adjusted EBITDA Margin 7 % (39 )% (5 )% (37 )% Reconciliation of Net Loss to Non-GAAP Net Income (Loss); and Net Loss per Common Share to Non-GAAP Net Loss per Common Share Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Net loss $ (3,229 ) $ (8,683 ) $ (22,710 ) $ (25,659 ) Stock-based compensation expense 2,327 2,263 8,126 5,210 Loss on change in fair value of warrant liability 16 22 1,233 60 Write-off of debt issuance costs (2) — — — 1,505 Acquisition related costs (3) 1,153 — 1,329 — Non-GAAP net income (loss) $ 267 $ (6,398 ) $ (12,022 ) $ (18,884 ) Dividends on preferred stock - declared and undeclared (1,523 ) — (1,987 ) — Non-GAAP net loss attributable to common stockholders $ (1,256 ) $ (6,398 ) $ (14,009 ) $ (18,884 ) Net loss per common share - basic and diluted $ (0.27 ) $ (0.52 ) $ (1.44 ) $ (1.56 ) Non-GAAP net loss per common share - basic and diluted (0.07 ) (0.39 ) (0.82 ) (1.15 ) Weighted-average common shares outstanding - basic and diluted 17,472 16,590 17,112 16,418 __________________________ (1) Relates to operating and financing ROU assets and acquired intangible assets. (2) Relates to the repayment and termination of our 2022 Loan in September 2019. (3) Includes external legal, accounting, and advisory costs, as well as gain on change in fair value of continent liability related to a stock price guarantee, associated with an acquisition. businesswire.com - 3 years ago
8. Profile Summary

Ontrak, Inc. OTRKP

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 7.3 M
Dividend Yield 0.00%
Description Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.
Contact 2200 Paseo Verde Parkway, Henderson, NV, 89052 https://www.ontrak-inc.com
IPO Date Aug. 28, 2020
Employees 102
Officers Mr. James J. Park Chief Financial Officer & Principal Accounting Officer Ms. Susan E. Etzel CPA Senior Vice President of Finance & Assistant Secretary Dr. Judith Feld M.D., M.P.H. Chief Medical Officer Ms. Mary Louise Elizabeth Osborne President & Chief Commercial Officer Ms. Sandy Gyenes Senior Vice President of Human Resources Ms. Lori Wheeless Senior Vice President of Digital Services Operations Ms. Brianna Brennan Chief Innovation Officer Mr. Arik Hill Chief Information Officer Ms. Sunmi Janicek Chief Compliance & Privacy Officer